Facebook Linkedin RSS Twitter Youtube
Home 2024

Obesity management

Amgen Raises NC Investment to $1.5B with Plans for Second Plant
Bioprocessing

Amgen Raises NC Investment to $1.5B with Plans for Second Plant

Weight Loss Drug Curbs Appetite, Burns Energy, Skips Side Effects
Drug Discovery

Weight Loss Drug Curbs Appetite, Burns Energy, Skips Side Effects

StockWatch: Investors Hammer Lilly as GLP-1 Sales Miss Forecasts
Drug Discovery

StockWatch: Investors Hammer Lilly as GLP-1 Sales Miss Forecasts

Seaport Eyes Platform, Pipeline Growth with $225M Series B
Drug Discovery

Seaport Eyes Platform, Pipeline Growth with $225M Series B

StockWatch: BioAge, Orum Reflect Renewed Interest in IPOs
Drug Discovery

StockWatch: BioAge, Orum Reflect Renewed Interest in IPOs

StockWatch: FDA Surprise Lifts Expectations for Applied’s Govorestat
Drug Discovery

StockWatch: FDA Surprise Lifts Expectations for Applied’s Govorestat

HAYA, Lilly Launch Up-to-$1B Metabolic Collaboration
Drug Discovery

HAYA, Lilly Launch Up-to-$1B Metabolic Collaboration

StockWatch: Lilly Narrows GLP-1 Revenue Gap with Novo Nordisk
Drug Discovery

StockWatch: Lilly Narrows GLP-1 Revenue Gap with Novo Nordisk

StockWatch: As Illumina Expands in Multiomics, Analyst Sees Threat to 10x
GEN Edge

StockWatch: As Illumina Expands in Multiomics, Analyst Sees Threat to 10x

Novo Nordisk, Flagship’s Metaphore Launch Obesity Collaboration
Industry News

Novo Nordisk, Flagship’s Metaphore Launch Obesity Collaboration

123Page 1 of 3
Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.